BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
Suhail Al-SalamCharu SharmaBachar O AfandiKhaled Al DahmaniAli S Al-ZahraniAmal Al ShamsiJuma Al KaabiPublished in: PloS one (2020)
BRAF V600E and KRAS mutation are seen in a significant number of PTC in the UAE. BRAF mutation is significantly correlated with large tumor size, positive surgical margins and lymph node metastasis suggesting an association between BRAF V600E mutation and tumor growth and spread.